Hims is officially phasing out its copycat weight-loss drugs, and the company's stock tumbled — again
After the FDA removed semaglutide injection products from a shortage list, compounders like Hims have 60-90 days to stop ...
Biggest stock movers Tuesday: Crypto stocks, HIMS, ZM, and more
Stock futures inched up Tuesday morning as investors assessed fresh comments from President Donald Trump on tariffs. Trump ...